Recent Quarter Total Invested
$78.39 M
Recent Quarter Institutional Ownership Percentage
28.23%
Total Invested of Last Quarter
$57.44 M
Ownership Percentage of Last Quarter
27.46%
Akebia Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 15.20 M | $20.06 M | 100.00% | 7.22% |
| ALERCE INVESTMENT MANAGEMENT, L.P. | 11/13/2024 | 5.75 M | $7.59 M | 0.00% | 2.73% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 4.75 M | $6.28 M | 4.81% | 2.26% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 3.72 M | $4.91 M | -5.03% | 1.77% |
| STATE STREET CORP | 11/14/2024 | 3.43 M | $4.53 M | 24.87% | 1.63% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 2.03 M | $2.69 M | -2.89% | 0.97% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 1.32 M | $1.75 M | -24.12% | 0.63% |
| MORGAN STANLEY | 11/14/2024 | 1.09 M | $1.44 M | 42.65% | 0.52% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 1.05 M | $1.38 M | 0.06% | 0.50% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 568,667 | $750,640 | -0.40% | 0.27% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 485,269 | $640,555 | 39.08% | 0.23% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 469,708 | $620,014 | -22.30% | 0.22% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 404,718 | $534,228 | 100.00% | 0.19% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 380,535 | $502,306 | 0.00% | 0.18% |
| BARCLAYS PLC | 11/19/2024 | 273,085 | $360,000 | 276.13% | 0.13% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 249,573 | $329,435 | 9.87% | 0.12% |
| RHUMBLINE ADVISERS | 11/12/2024 | 242,876 | $320,589 | -1.69% | 0.12% |
| SAPIENT CAPITAL LLC | 10/11/2024 | 200,000 | $264,000 | 0.00% | 0.10% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 187,849 | $247,961 | 23.71% | 0.09% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 170,374 | $224,893 | -3.09% | 0.08% |
| FRANKLIN RESOURCES INC | 11/12/2024 | 167,184 | $220,683 | 100.00% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 164,570 | $217,232 | -33.86% | 0.08% |
| UBS GROUP AG | 11/14/2024 | 153,662 | $202,833 | 7.59% | 0.07% |
| TUDOR INVESTMENT CORP ET AL | 11/14/2024 | 142,274 | $187,802 | 0.00% | 0.07% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 141,049 | $186,185 | 100.00% | 0.07% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 140,167 | $185,020 | 263.55% | 0.07% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 133,934 | $177,000 | 100.00% | 0.06% |
| CITADEL ADVISORS LLC | 11/14/2024 | 127,500 | $168,300 | 38.89% | 0.06% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 126,648 | $168,000 | 0.00% | 0.06% |
| INVESCO LTD. | 11/12/2024 | 119,774 | $158,102 | -7.71% | 0.06% |
| CREATIVE PLANNING | 10/11/2024 | 116,172 | $153,347 | 4.95% | 0.06% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 114,148 | $150,675 | 100.00% | 0.05% |
| COREBRIDGE FINANCIAL, INC. | 11/13/2024 | 111,229 | $146,822 | -0.61% | 0.05% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 108,200 | $142,824 | -31.65% | 0.05% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 99,298 | $131,073 | 3.33% | 0.05% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 98,900 | $130,548 | -77.09% | 0.05% |
| JPMORGAN CHASE & CO | 11/08/2024 | 98,546 | $130,081 | 10.87% | 0.05% |
| HIGHTOWER ADVISORS, LLC | 11/14/2024 | 93,350 | $122,000 | 5.66% | 0.04% |
| TD WATERHOUSE CANADA INC. | 11/12/2024 | 90,618 | $114,976 | 0.07% | 0.04% |
| ORCHARD CAPITAL MANAGEMENT, LLC | 11/13/2024 | 84,716 | $111,825 | -2.43% | 0.04% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 82,961 | $109,509 | 100.00% | 0.04% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 78,444 | $103,546 | 100.00% | 0.04% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 77,640 | $102,485 | 0.00% | 0.04% |
| SG AMERICAS SECURITIES, LLC | 10/03/2024 | 71,965 | $95,000 | 117.13% | 0.03% |
| CITADEL ADVISORS LLC | 11/14/2024 | 71,200 | $93,984 | -8.13% | 0.03% |
| VOYA INVESTMENT MANAGEMENT LLC | 11/14/2024 | 70,361 | $92,877 | -1.86% | 0.03% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 11/13/2024 | 68,064 | $89,844 | 25.68% | 0.03% |
| PRIVATE ADVISOR GROUP, LLC | 10/22/2024 | 58,816 | $77,637 | -1.36% | 0.03% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 55,746 | $74,000 | -25.75% | 0.03% |
| CWA ASSET MANAGEMENT GROUP, LLC | 11/01/2024 | 49,000 | $64,680 | 100.00% | 0.02% |
Akebia Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of AKBA shares?
During the previous two years, 154 institutional investors and hedge funds held shares of Akebia Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 15.2 M
Alerce Investment Management, L.P.: 5.75 M
GEODE CAPITAL MANAGEMENT, LLC: 4.75 M
RENAISSANCE TECHNOLOGIES LLC: 3.72 M
STATE STREET CORP: 3.43 M
JACOBS LEVY EQUITY MANAGEMENT, INC: 2.03 M
-
What percentage of Akebia Therapeutics, Inc. stock is owned by institutional investors?
28.23% of Akebia Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at AKBA ?
Institutional investors have bought a total of 62.33 M shares in the last 24 months. This purchase volume represents approximately $116.55 M in transactions.